Joinn Laboratories(China)Co.,Ltd. (HKG:6127)
Hong Kong · Delayed Price · Currency is HKD 23.04
+0.12 (0.52%)
Sep 30, 2025, 4:08 PM HKT
HKG:6127 Revenue
Joinn Laboratories(China)Co.,Ltd. had revenue of 381.24M CNY in the quarter ending June 30, 2025, a decrease of -27.32%. This brings the company's revenue in the last twelve months to 1.84B, down -16.99% year-over-year. In the year 2024, Joinn Laboratories(China)Co.,Ltd. had annual revenue of 2.02B, down -15.07%.
Revenue (ttm)
1.84B CNY
Revenue Growth
-16.99%
P/S Ratio
13.23
Revenue / Employee
692.89K CNY
Employees
2,652
Market Cap
26.64B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.02B | -358.15M | -15.07% |
| Dec 31, 2023 | 2.38B | 108.52M | 4.78% |
| Dec 31, 2022 | 2.27B | 751.29M | 49.54% |
| Dec 31, 2021 | 1.52B | 440.78M | 40.97% |
| Dec 31, 2020 | 1.08B | 436.53M | 68.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines AG | 35.81B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| JD Health International | 71.34B |
| Innovent Biologics | 12.52B |
| WuXi Biologics | 21.98B |
| Sino Biopharmaceutical | 33.49B |
| Akeso | 2.75B |
| Sichuan Kelun-Biotech Biopharmaceutical | 1.64B |